BU-NOT-SET

CONTACT US
The Recipharm Journey
  • Corporate
Eyes
Insight
Solubility enhancement
  • Drug substance
Man holding liquid container
Fact sheet
Unlocking the key changes to Annex 1
  • Manufacturing
Eyes
Insight
Trends impacting drug dosage forms
  • Drug product
Product line
Insight
Relocation of the production of pharmaceuticals: a strategic endeavour for the European Union
  • Industry trends
Eyes
Insight
Outsourcing solid dose manufacturing trends
  • Manufacturing
Eyes
Insight
Strategic outsourcing of analytical testing solutions to speed up time-to-market
  • Analytical chemistry
Eyes
Insight
Recipharm Cannabinoids
  • Drug product
Eyes
Insight
Explore Recipharm's Full Service Offering
  • Corporate
Recipharm_packaging
Brochure
White paper
  • Biologics
Product Quality in the Advanced Therapies Manufacturing
Insight
  • Biologics
Navigating ATMP fill and finish complexities
Insight
  • Biologics
The power of analytics and AI in the era of continuous RNA manufacturing
Insight
  • Biologics
Reimagining the RNA manufacturing space: An interview with ReciBioPharm’s leaders
Insight
  • Biologics
Unlocking the potential of mRNA: Inside ReciBioPharm's Watertown site
Insight
  • Biologics
Industry 5.0 in action: AI-driven continuous manufacturing for RNA therapeutics
Insight
  • Drug product
  • Manufacturing
Choosing the optimal container format for sterile drug products
Insight
  • Manufacturing
FDA inspection success at Recipharm’s site in Bengaluru, India
Fact sheet
  • Drug product
  • Manufacturing
Lyophilisation Services